SNSEHealthcareNano-Cap
Sensei Biotherapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Sensei Biotherapeutics, Inc. (SNSE), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are SNSE insiders buying or selling?
Sensei Biotherapeutics, Inc. insiders reported 99 open-market buys ($9.6M) and 10 sells ($8.1M) across 109 Form 4 filings — a net buying position of $1.5M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 1, 2026)
Total Form 4 filings
109
SEC EDGAR
Insider filers
7
Insider buys (99)
$9.6M
Insider sells (10)
$8.1M
Insider sentiment
Net buyingNet insider flow of $1.5M in net buying. 2 insider buys in the last 90 days.
Recent SNSE insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Cambrian BioPharma Inc | 10% Owner | Sale | 25.0K | $20.02 | $500.5K |
| Jun 1, 2026 | James Peyer | Other, 10% Owner | Sale | 25.0K | $20.02 | $500.5K |
| May 15, 2026 | Israel A Englander | 10% Owner | Sale | 12.9K | $30.85 | $396.8K |
| May 15, 2026 | Israel A Englander | 10% Owner | Purchase | 9.4K | $32.33 | $305.2K |
| May 15, 2026 | Israel A Englander | 10% Owner | Purchase | 27.3K | $26.66 | $728.9K |
| Dec 10, 2025 | Cambrian BioPharma Inc | 10% Owner | Sale | 6.6K | $8.25 | $54.6K |
| Dec 10, 2025 | James Peyer | Other, 10% Owner | Sale | 6.6K | $8.25 | $54.6K |
| Dec 8, 2025 | Cambrian BioPharma Inc | 10% Owner | Sale | 21.3K | $10.93 | $232.7K |
| Dec 8, 2025 | James Peyer | Other, 10% Owner | Sale | 21.3K | $10.93 | $232.7K |
| Sep 13, 2023 | John Celebi | President and CEO | Purchase | 500 | $0.85 | $425 |
| Jun 2, 2023 | Christian Angermayer | 10% Owner | Sale | 3.4M | $1.58 | $5.4M |
| Feb 28, 2023 | Christian Angermayer | 10% Owner | Purchase | 2.2K | $1.61 | $3.5K |
| Jun 10, 2022 | James Peyer | Director, 10% Owner | Purchase | 1.2K | $3.20 | $3.8K |
| Jun 10, 2022 | Cambrian BioPharma Inc | 10% Owner | Purchase | 1.2K | $3.20 | $3.8K |
| Apr 21, 2022 | James Peyer | Director, 10% Owner | Purchase | 9.5K | $14.34 | $136.2K |
| Apr 21, 2022 | James Peyer | Director, 10% Owner | Purchase | 752 | $19.75 | $14.9K |
| Apr 21, 2022 | Cambrian BioPharma Inc | 10% Owner | Purchase | 9.5K | $14.34 | $136.2K |
| Apr 21, 2022 | Cambrian BioPharma Inc | 10% Owner | Purchase | 752 | $19.75 | $14.9K |
| Mar 2, 2022 | Cambrian BioPharma Inc | 10% Owner | Purchase | 1.2K | $3.20 | $3.8K |
| Mar 2, 2022 | James Peyer | Director, 10% Owner | Purchase | 1.2K | $3.20 | $3.8K |
| Mar 1, 2022 | James Peyer | Director, 10% Owner | Purchase | 2.5K | $3.60 | $9.0K |
| Mar 1, 2022 | Cambrian BioPharma Inc | 10% Owner | Purchase | 2.5K | $3.60 | $9.0K |
| Feb 28, 2022 | James Peyer | Director, 10% Owner | Purchase | 2.5K | $3.65 | $9.1K |
| Feb 28, 2022 | Cambrian BioPharma Inc | 10% Owner | Purchase | 2.5K | $3.65 | $9.1K |
| Feb 25, 2022 | Cambrian BioPharma Inc | 10% Owner | Purchase | 17.5K | $3.65 | $64.0K |
Showing the 25 most recent of 109 Form 4 filings for Sensei Biotherapeutics, Inc..
Most active SNSE insiders
- Cambrian BioPharma Inc50 filings
- James Peyer50 filings
- Israel A Englander3 filings
- Christian Angermayer2 filings
- Robert Hamilton Pierce2 filings
Ask anything about SNSE insider activity
Use Trabud's AI agent to query Sensei Biotherapeutics, Inc.'s Form 4 history in plain English — "Show me SNSE CEO purchases this year" or compare it against any other ticker.
Open the AI agentSNSE insider trading FAQ
Are Sensei Biotherapeutics, Inc. insiders buying or selling?
Across 109 SEC Form 4 filings, Sensei Biotherapeutics, Inc. (SNSE) insiders reported 99 open-market purchases totaling $9.6M and 10 sales totaling $8.1M. That is a net buying position of $1.5M.
How many insiders trade SNSE stock?
7 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Sensei Biotherapeutics, Inc.. The most recent filing was accepted on Jun 1, 2026.
Where does Trabud get SNSE insider trading data?
All SNSE insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.